US Patent Issued to Takeda Pharmaceutical, Memorial Sloan-Kettering Cancer Center on July 7 for "CCR8 antibodies, antibody conjugates, and uses thereof" (Massachusetts, New Hampshire, New York Inventors)

ALEXANDRIA, Va., July 7 -- United States Patent no. 12,673,112, issued on July 7, was assigned to Takeda Pharmaceutical Co. Ltd. (Osaka, Japan) and Memorial Sloan-Kettering Cancer Center (New York).

"CCR8 antibodies, antibody conjugates, and uses thereof" was invented by Adrian Schwartz-Mittleman (Cambridge, Mass.), Cierra Casson (Cambridge, Mass.), Sarah Hesse (Cambridge, Mass.), Natalie Roy D'Amore (Cambridge, Mass.), Cory Ahonen (Lebanon, N.H.), George Plitas (Manhattan, N.Y.) and Alexander Rudensky (Manhattan, N.Y.).

According to the abstract* released by the U.S. Patent & Trademark Office: "Disclosed herein are antibodies that bind to CCR8 (e.g., human CCR8) and anti-CCR8 antibody drug conjugates (ADC)."

The patent was filed on Dec....